{
  "release_id": "73130c34862e2d06",
  "id": "cardio:guideline-uspstf-2022-statin",
  "owner": "cardio",
  "kind": "guideline",
  "slug": "guideline-uspstf-2022-statin",
  "name": "USPSTF 2022: statin use for primary prevention of CVD in adults",
  "aliases": [
    "Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement"
  ],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "The 2022 recommendation statement issued by the US Preventive Services Task Force on taking a statin to prevent cardiovascular disease in adults who do not already have it. The Task Force grades its advice by age, by risk factors and by the estimated chance of a cardiovascular event over the next ten years. This statement updates its 2016 recommendation.",
  "summary_technical": "JAMA 2022;328(8):746-753, doi 10.1001/jama.2022.13044, PMID 35997723. The USPSTF page dates the final statement August 23, 2022. Only the PubMed abstract and that date line were read; the full statement was not. Grades as the abstract labels them: B for ages 40 to 75 with one or more risk factors (abnormal blood fats, diabetes, hypertension, smoking) and a 10-year risk, as estimated, of at least 10%; C for the same group at 7.5% to under 10%; and an I statement from age 76. The USPSTF permits reuse of its work only under its copyright notice, so this atlas states the recommendations in its own words, with a citation and a link.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-10-15",
  "last_evidence_check": "2026-10-15",
  "next_review_due": null,
  "identifiers": [
    {
      "scheme": "doi",
      "value": "10.1001/jama.2022.13044",
      "normalized_value": "10.1001/jama.2022.13044",
      "match": "exact",
      "version": null,
      "label": null,
      "from_source": true
    },
    {
      "scheme": "pmid",
      "value": "35997723",
      "normalized_value": "35997723",
      "match": "exact",
      "version": null,
      "label": null,
      "from_source": true
    }
  ],
  "navigation": {
    "cardio": {
      "system": [
        "heart",
        "blood-vessels"
      ],
      "condition-area": [
        "risk-and-prevention",
        "coronary-and-vascular-disease"
      ]
    }
  },
  "payload": {
    "source": "cardio:uspstf-2022-statin",
    "issuers": [
      "core:uspstf"
    ],
    "edition": "2022 recommendation statement",
    "published": "2022-08-23",
    "planned_update": null,
    "status": "not_checked",
    "scope": "Primary prevention of cardiovascular disease with statins in adults aged 40 or older without known cardiovascular disease.",
    "plain_interpretation": null
  },
  "content_digest": "2db1592a0a6ec3327f26ecf4d7d11b2316204b7158be686694a2de3912b60cd4",
  "review": {
    "content_digest": "2db1592a0a6ec3327f26ecf4d7d11b2316204b7158be686694a2de3912b60cd4",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "authored_by",
        "label": "Issuer: the Task Force is named as the author in the PubMed record",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "core:uspstf",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:pubmed-35997723-2026-10-15",
          "locator": "AuthorList, CollectiveName"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": []
  },
  "page_path": "guidelines/guideline-uspstf-2022-statin/",
  "context_path": "api/v1/context/cardio--guideline-uspstf-2022-statin.md"
}